Stockreport

Citius Oncology Announces Pricing of $9.0 Million Registered Direct Offering and Concurrent Private Placement [Yahoo! Finance]

Citius Oncology, Inc.  (CTOR) 
PDF Pharmaceuticals, Inc. ("Citius Pharma") (Nasdaq: CTXR), a late-stage biopharmaceutical company developing and commercializing first-in-class critical care products, toda [Read more]